1 Novel histone deacetylase inhibitors bearing a 4-piperidin-4-yl-triazole scaffold as antitumor agents.

2 Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study.

3 Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.

4 Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates.

5 Spectra and Photorelaxation of Hydroxyphenyl-benzotriazole-Type UV Absorbers: From Monomers to Nanoparticles.

6 Cobalt-Catalyzed Intermolecular Markovnikov Hydroamination of Nonactivated Olefins: -Selective Alkylation of Benzotriazole.

7 Second generation 4,5,6,7-tetrahydrobenzo[]thiazoles as novel DNA gyrase inhibitors.

8 Protonation states of central amino acids in a zinc metalloprotease complexed with inhibitor: Molecular mechanics optimizations and ab initio molecular orbital calculations.

9 Inhibition of MAPKs Signaling Pathways Prevents Acrolein-Induced Neurotoxicity in HT22 Mouse Hippocampal Cells

10 prospects for circumventing aminoglycoside kinase mediated antibiotic resistance

11 a medicinal herb scutellaria lateriflora inhibits prp replication in vitro and delays the onset of prion disease in mice

12 design, synthesis, and biological evaluation of axitinib derivatives

13 inhibitory activities of alkyl syringates and related compounds on aflatoxin production

14 pengaruh penambahan inhibitor alami terhadap laju korosi pada material pipa dalam larutan air laut buatan

15 the process and strategy for developing selective histone deacetylase 3 inhibitors

16 multiple chemical scaffolds inhibit a promising leishmania drug target

17 handling anisotropy and strength of fiber-reinforced plastic via local inhibition of the curing process

18 Acetylcholinesterase Inhibitory Activity and Chemical Composition of Commercial Essential Oils

19 Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

20 Cholinesterase inhibitors for Alzheimer's disease

21 Chalcones as potent tyrosinase inhibitors: the importance of a 2, 4-substituted resorcinol moiety

22 Synthesis of benzophenone hydrazone analogs and their DPPH radical scavenging and urease inhibitory activities

23 New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors

24 Sulfonamide derivatives as inhibitors: in silico approach.

25 Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.

26 Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2.

27 Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors.

28 Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.

29 Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors.

30 Purification and characterization of a cystatin like thiol protease inhibitor from Brassica nigra.

31 The Critical Role of X Chromosome-linked Inhibitor of Apoptosis (XIAP) in Differential Synergism Induced by Pentachlorophenol and Copper-1,10-phenanthroline Complex in Normal and Cancer Liver Cells.

32 Purification and characterization of a cystatin like thiol protease inhibitor from Brassica nigra

33 Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives

34 Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors.

35 EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

36 Cyrmenins, new beta-methoxyacrylate inhibitors of the electron transport. Production, isolation, physico-chemical and biological properties.

37 EI-1941-1 and -2, novel interleukin-1 beta converting enzyme inhibitors Produced by Farrowia sp. E-1941. II. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

38 Convenient framework of poly functionalized (E)-2-benzylideno-(Z)-carbazolylideno cyanoacetamides via rearrangements as an efficient antibiofilm inhibitors with SAR study.

39 A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1.

40 Design and synthesis of 3-(3-((9 H-carbazol-4-yl)oxy)-2-hydroxypropyl)-2-phenylquinazolin-4(3 H)-one derivatives to induce ACE inhibitory activity

41 Inhibitory effects of two types of food additives on biofilm formation by foodborne pathogens.

42 Phenolic profile, antioxidant and enzyme inhibitory activities of Ottelia acuminata, an endemic plant from southwestern China

43 Cholinesterase inhibitors as Alzheimer's therapeutics (Review).

44 Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.

45 Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.

46 Tubes for detection of cholinesterase inhibitors-Unique effects of Neusilin on the stability of butyrylcholinesterase-impregnated carriers.

47 Coumarin derivatives as acetyl- and butyrylcholinestrase inhibitors: An in vitro, molecular docking, and molecular dynamics simulations study.

48 Optimization of ultrasound-assisted extraction of total phenolic contents and antioxidant activity using response surface methodology from jujube leaves (Ziziphus jujuba) and evaluation of anticholinesterase inhibitory activity

49 Acute Rat and Mouse Oral Toxicity Determination of Anticholinesterase Inhibitor Carbamate Pesticides: A QSTR Approach

50 Flavone glycosides from Sicyos angulatus and their inhibitory effects on hepatic lipid accumulation.

51 DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of : In Vitro and Analyses.

52 Flavonol glycosides with α-Glucosidase inhibitory activities and new flavone C-diosides from the leaves of machilus konishii

53 Lysozyme-luteolin binding: molecular insights into the complexation process and the inhibitory effects of luteolin towards protein modification.

54 Synthesis, biological evaluation and docking studies of chalcone and flavone analogs as antioxidants and acetylcholinesterase inhibitors

55 Investigation of potent inhibitors of cholinesterase based on thiourea and pyrazoline derivatives: Synthesis, inhibition assay and molecular modeling studies.

56 Design, Synthesis, and Structure-Activity Relationships of 1,2,3-Triazole Benzenesulfonamides as New Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors.

57 Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors.

58 Inhibitory effects of leaf extract of on and characterization of novel inhibitory compounds by GC-MS analysis.

59 Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.

60 Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors.

61 To detect the minimum inhibitory concentration and time-kill curve of shiitake mushroom on periodontal pathogens: An study.

62 Discovery of tropinone-thiazole derivatives as potent caspase 3/7 activators, and noncompetitive tyrosinase inhibitors with high antiproliferative activity: Rational design, one-pot tricomponent synthesis, and lipophilicity determination.

63 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

64 Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP–E2F1–DNA damage response pathway axis

65 PIM kinase inhibitors: Structural and pharmacological perspectives.

66 Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.

67 "Favoring my playmate seems fair": Inhibitory control and theory of mind in preschoolers' self-disadvantaging behaviors.

68 Erratum to "Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac".

69 Comparison on total phenols content and antioxidant activity and inhibitory effect on α-glucosidase activity of water chestnut shells (Trapa natans shells) from different locations

70 Evaluation of extracellular polymeric substances extracted from waste activated sludge as a renewable corrosion inhibitor.

71 Synthesis, activity testing and molybdenum(VI) complexation of Schiff bases derived from 2,4,6-trihydroxybenzaldehyde investigated as xanthine oxidase inhibitors.

72 Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro-1 H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase.

73 In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

74 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.

75 Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells.

76 Acid-mediated synthesis of fully substituted 1,2,3-triazoles: Multicomponent coupling reactions, mechanistic study, synthesis of serine hydrolase inhibitor and its derivatives

77 Discovery and biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors

78 Evaluating the antioxidant and acetylcholinesterase inhibitory activity of three Centaurea species

79 α-Glucosidase inhibitory activity and in vivo antihyperglycemic effect of secondary metabolites from the leaf infusion of Ocimum campechianum mill.

80 Isolation of Chemical Constituents of Centaurea virgata Lam. and Xanthine Oxidase Inhibitory Activity of the Plant Extract and Compounds.

81 Screening for antioxidant and antimutagenic properties of extracts from centaurea pterocaula as well as their enzyme inhibitory potentials

82 Antioxidant, Anti-Inflammatory, Acetylcholinesterase Inhibitory and Antimicrobial Activities of Turkish Endemic Centaurea antiochia var. Praealta

83 Centaurea karduchorum Boiss. from Eastern Anatolia: Phenolic composition, antioxidant and enzyme inhibitory activities

84 Pharmacological characterization of the seven human NOX isoforms and their inhibitors.

85 Protective effects of Gαq-RGS2 signaling inhibitor in aminophylline induced cardiac arrhythmia.

86 Inhibitory Effect of Epigallocatechin Gallate, Epigallocatechin, and Gallic Acid on the Formation of N-Nitrosodiethylamine In Vitro.

87 Effects of nitrification inhibitors on gross N nitrification rate, ammonia oxidizers, and NO production under different temperatures in two pasture soils.

88 Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.

89 An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation.

90 Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N²-Thiophenecarbonyl- and N²-Tosylanthranilamides.

91 Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.

92 Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas.

93 Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.

94 Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.

95 Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor

96 Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin).

97 Synthesis and Evaluation of Novel Pyrazole Ethandiamide Compounds as Inhibitors of Human THP-1 Monocytic Cell Neurotoxicity.

98 Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors.

99 Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents.

100 Design, synthesis and biological evaluation of 2-H pyrazole derivatives containing morpholine moieties as highly potent small molecule inhibitors of APC–Asef interaction

101 Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential

Keyword Connections

Journals

Research Groups

Bibliographies